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Matrix tablets are drug delivery devices designed to release a drug in a controlled manner over
an extended period of time. We develop a cellular automaton (CA) model for the dissolution and
release of a water-soluble drug and excipient from a matrix tablet of water-insoluble polymer. Cells
of the CA are occupied by drug, excipient, water or polymer and the CA updating rules simulate
the dissolution of drug and excipient and the subsequent diffusion of the dissolved substances. In
addition we simulate the possible fracture of brittle drug and excipient powders during the tablet
compression and the melting of the polymer during a possible thermal curing process. Different
stirring mechanisms that facilitate the transport of dissolved drug in the fluid in which the tablet is
immersed are modeled in the water cells adjacent to the boundary of the tablet. We find that our
simulations can reproduce experimental drug release profiles. Our simulation tool can be used to
streamline the formulation and production of sustained release tablets.
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I INTRODUCTION
I. INTRODUCTION
The design of controlled release systems has been an active area of research in pharmaceuti-
cal science and industry for decades. The most common systems include coated systems, matrix
tablets, eroding tablets and oral osmotic therapeutic systems [1–3]. The present work focuses on
the development of a mathematical model and simulation tool that describes the sustained drug
release observed in matrix tablets. Matrix tablets are devices that deliver a drug in a controlled
manner over an extended period of time. A preferred manufacturing method is to mix the drug with
pharmaceutically inactive excipient and polymer powders. This powder mixture is then compressed
in a die at high pressures (e.g. 70−200MPa) and may be cured for 8-24 hours at 40−70 ◦C. Until
now, pharmaceutical scientists were restricted to fabrication of experimental tablets to understand
the influence of parameters such as the powder composition, the compaction pressure and the curing
temperature and duration. As this is expensive and time consuming, the need for mathematical
modeling and simulation tools becomes evident, see [4–7] for earlier works. The aim of this work
is to provide a tool that allows pharmaceutical scientists to mimic the release processes in matrix
tablets.
In our earlier work [7] we proposed two mathematical models for the release of a water-soluble
drug from a polymer/excipient matrix tablet. The first model used a biased random walk on the
contact graph of a random sphere packing. The second model was based on a system of reaction-
diffusion partial differential equations for the concentrations of dissolved and undissolved drug and
excipient, respectively. While the first discrete model predicted partial release of drug from the
tablet in agreement with experimental observations [7], the second continuous model proved better
at capturing a change from convex to concave in several experimental release profiles. With the
cellular automaton (CA) model presented here, we explicitly model the initial wetting process of the
tablet when water passes through pores into the interior of the tablet, followed by the dissolution
of the drug and the excipient. We also incorporate the fracture of the brittle drug and excipient
powders during the compaction process and the partial melting of the polymer during an optional
thermal treatment of the compressed tablet. This results in the formation of larger connected
regions of polymer that may entrap drug and prevent it from leaving the tablet. Finally, we also
allow to simulate different stirring protocols that aide the transport of dissolved and released drug
away from the tablet [8]. We find that our model has the capacity to reproduce quantitatively
experimental release curves of tablets formulated from different powder mixtures and subjected to
different heating protocols.
Cellular automata have shown their usefulness in many sciences since their introduction by Ulam
and von Neumann about 70 years ago. Let us mention here only some applications to traffic
networks [9], neural networks [10], tumor growth [11] and statistical mechanics [12]. They allow for
greater detailed modeling of internal processes in “cells” that is generally not possible in coarse-
grained partial differential equation models. The recent advances in computational technology have
made earlier restrictions to small numbers of cells less stringent, if not obsolete.
The remainder of this paper is organized as follows. We describe in Section II the cellular
automaton model in detail, paying special attention to the initialization process. Section III contains
several simulation results, where we explore the influences of the respective parameters. In Section
we discuss our results and indicate future research. Appendix A lists parameter values used in the
simulations and instructions how to download and use our simulation tool.
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II. THE CELLULAR AUTOMATON MODEL
A. General description and program flow
The cellular automaton recreates the three-dimensional cylindrical geometry of the matrix tablet.
Each particle in the tablet is represented by a vertex in a cubic lattice that fills out a cylindrical
domain. The diameter of the cylinder and height as a fraction of the diameter are specified by the
user. A vertex interacts with its 6 closest von Neumann neighbors by a set of rules designed to
imitate the actual physics of the release process, see Figure 1.
d
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FIG. 1: (Left) The tablet is represented by a cubic lattice in a cylindrical domain. Each grid
element, indicated here by a colored cube, can be in one of five states: drug (purple), polymer
(red), excipient (green), empty (black) and water (blue). This tablet is surrounded by a layer
of water cells (not shown here). (Right) Each element interacts with its 6 closest von Neumann
neighbors.
Every cell can be in one of five states, namely drug (D), polymer (P), excipient (X), empty (E)
and water (W). In the initialization phase the cells of the lattice are randomly assigned a state so
that the distribution of cells of type D, P and X are those prescribed by the composition of the
powder mixture, with the possible formation of a polymer shell under thermal treatment. Empty
cells are created during the heating and compression phase. Cells of type W surround the tablet at
all times. The wet cells are further characterized by two quantities, the concentration of drug and of
excipient, respectively. These quantities are real numbers between 0 and 1, where a concentration
of 1 corresponds to a saturated solution. Naturally, the concentrations change as water travels
into the tablet and solid particles dissolve. To avoid clumsy triple index notation, we simply write
cD(x, t) and cX(x, t) for the concentration of drug and excipient, respectively, in the cell located
at vertex x of the lattice at time t. Throughout the paper, let N(x) denote the von Neumann
neighborhood of vertex x.
After initialization of the tablet according to the user’s specification, the tablet’s state is repeat-
edly updated until either a maximum number of iterations have been executed or the amount of
released drug ceases to change significantly. Each iteration of the update rules advances the sim-
ulation clock by a certain fixed amount of time which depends on the model parameters. Finally,
we also model the transport of dissolved drug in the boundary layer surrounding the tablet. The
details of the simulation are described in the following sections.
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FIG. 2: Schematic representation of the flow. During each update of the tablet, a new tablet state
is created from the existing one which is afterwards cleared to free memory.
B. Initialization
The composition of the tablet is determined by the fractions of drug, polymer and excipient
in the powder, which we denote here by PD, PP and PX , respectively. Thermal treatments and
compaction studies on Eudragit-RLPO matrix tablets revealed that the particles of the powder
mixture move and diffuse during the heating process [13, 14], coalescing the polymer particles and
forming matrices with decreased porosity and increased tortuosity. Porosity and tortuosity are
important factors that affect the dissolution and release rate, as well as the possible formation of
a thin polymer film on the surface of the tablet [13]. The release kinetics from laboratory studies
show that, as the amount of polymer is increased, drug release from heated tablets approaches
“first-order kinetics”, i.e. nearly linear release with respect to time, see [7, Figure 7].
We simulate the creation of a film, or shell on the outside of the tablet as an effect of heating,
as suggested in [13]. In the model, polymer particles can move towards the surface during thermal
treatment, resulting in a higher chance of polymer being found on the tablet surface than in the
interior. The user specifies the thickness of the shell layer (w in the program) and an imbalance
factor b ≥ 1 that represents the preference of polymer particles to locate in the shell over the
remainder of the tablet. The distribution of particles is then computed as follows. Let nS denote
the number of cells (of any type) in the shell layer, and let nT denote the number of cells in the
remainder of the tablet. To simulate shell formation, a number of nPS = nS min{bPD, 1} polymer
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Complete shell ï no release (w = 2)
FIG. 3: An example of the formation of a polymer shell after thermal treatment. The tablet
contains 50% polymer. Polymer cells are shown in white, drug and excipient cells are shown in
black, and gray cells represent mixtures of polymer and other particles. (Left) b = 1, w = 1 (default)
, Center: b = 2, w = 1, giving a shell with some “holes”. (Right) b = 2, w = 2, giving a complete
shell allowing no release. All other parameters are given in Table I.
cells are randomly assigned to cells in the shell layer of the tablet. The remaining polymer cells,
whose number is nPT = PD(nS + nT ) − nPS are randomly assigned to the interior of the tablet.
All unoccupied tablet cells (including cells in the shell layer) are then reshuffled, and are assigned
to drug or excipient states, according to their prescribed fractions in the tablet. It should be
emphasized that setting b = 1 results in no shell formation. See Figure 3 for an illustration of
simulated shell formations, and Figure 8, top left panel, for a comparison of release curves with and
without shells.
Experimental release curves at various polymer concentrations, curing temperatures and com-
pression pressures show two distinctive characteristics that must be matched by a mathematical
model. These are the initial slope of the release curve, and the amount of drug that is not released
after a certain period of time, i.e. the “trapped” drug mass, when the release curve has flattened.
In order get the observed range of trapped drug mass, the model must reflect the deformation of
particles under pressure and the fusing of polymer particles under thermal treatment (similar to
sintering). We emulate these effects by refining the original grid and by allowing polymer particles
to move into adjacent grid elements, increasing tortuosity and the likelihood of trapping. First,
each grid element is subdivided into 8 subcells of equal size. If the grid element was in state D
or X, corresponding to drug or excipient particles, then the states of half of these subcells are
changed to E, empty. The new empty, state E subcells are located in opposing diagonal elements.
This subdivision of the cells corresponds to the breaking down of brittle particles under pressure.
Since polymer particles do not break under pressure, they are subjected to a different “heating”
rule. Thermal treatment is modeled by swapping void subcells and polymer subcells if a polymer
particle is located adjacent to a drug or excipient particle. If a polymer particle is adjacent to
several non-polymer particles, one of these neighbors is chosen randomly and subcells are swapped.
The processes of subdivision and subcell swapping are shown graphically in Figure 4. The result is
a virtual tablet that resembles an actual tablet after thermal treatment.
After initialization, the simulation domain is a cylindrical subregion of a cubic lattice, where each
grid cell has side length equal to L. If compression is used, then the side length is half the size
provided by the user L = y/2. The update rules are applied to this computational domain, so that
a grid cell is one of these cells of length L, and the number of cells in one direction of the cubic
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Initialize
Initial Drug Cell Subdivided Cell with Empty Sub-cells
Polymer Before Drug Before Polymer After Drug After
sub-cells swapped
FIG. 4: Diagram representing the grid subdivision and “swapping” algorithm used to simulate
polymer deformation and spreading. Each grid element is subdivided into 8 sub-cells, and empty
(black) sub-cells are created in drug or excipient grid elements (brown). Polymer sub-cells (blue)
are swapped with empty (black) sub-cells during the simulation of thermal treatment.
lattice is n/L. See Figure 2 for a schematic overview of the program flow.
C. Updating rules
The cell states are updated according to their present status and the following rules. Table I lists
all user-defined parameters and their default values.
1. Wetting. For a cell of type E we simulate its filling with water from neighboring cells of type
W due to capillarity. If a cell of type E has at least one neighbor of type W, then its status
is changed to W, otherwise no action is taken.
2. Dissolution. A cell of type D or X that is in contact with cells of type W, can be replaced
by a W cell. Assume that cell x is in state D, the case that a cell is in state X follows the
obvious modifications. Denote by nW (x) the number of neighboring water cells of cell x and
by NW (x) the set of all neighbors of type W. The dissolution capacity of the water in the
neighborhood of cell x is
S = 1− 1
nW (x)
∑
y∈NW (x)
c(y, t).
Note that S ∈ [0, 1]. We interpret S as the propensity of the particle at position x to dissolve,
and we implement this by allowing the particle at x to begin to dissolve with probability S.
In the CA algorithm a random number r is drawn uniformly from [0, 1], and if r < S, the
cell’s status is set to W and the concentration of the substance that just dissolved is set to 1,
while the other concentration remains at 0.
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3. Diffusion. Cells of type W have two concentrations associated with them, the concentration
of dissolved drug, and the concentration of dissolved excipient. These concentrations are
updated according to the following rule, which is a discretized version of the continuous
diffusion equation
c(x, tm+1) = c(x, tm) + Dˆ
 ∑
y∈NW (x)
c(y, tm)− nW (x)c(x, tm)

where c(x, tm) denotes the concentration in cell x in the updated tablet and Dˆ is the diffusion
rate of the dissolved substance in cell x relative to the expected time that it takes the fastest
dissolved substance to diffuse across one grid element. More precisely,
Dˆ =
Di
6 max{Ddrug, Dexcipient} ,
and i stands for “drug” or “excipient”. This choice ensures that the new value satisfies
0 ≤ c˜(x) ≤ 1, see Appendix B for more details.
4. Transport. Once dissolved drug or excipient reaches the boundary of the tablet, it must diffuse
into the surrounding medium. The concentrations in the grid cells surrounding the tablet are
initially set to zero. As molecules diffuse out from the tablet, the concentrations of drug and
excipient are updated in the surrounding layer of water cells. Since the tablet is assumed to sit
in a large amount of fluid, we can assume that concentrations far from the tablet are relatively
constant. Thus we only model the concentrations in water cells adjacent to the tablet, we call
the “boundary layer”. In order to simulate different stirring mechanisms, the concentrations
in cells in the boundary layer are multiplied by a factor f ∈ [0, 1] which is provided by the
user.
Since particles dissolve and diffuse at different rates, the real time interval corresponding to one
iteration step, ∆t, is calculated prior to execution of the main loop. Based on rates provided by
the user, ∆t is set to be the smallest of the four quantities.
• The average time it takes for a drug respectively excipient particle of mass corresponding to
one subcell to dissolve.
• The average time it takes for a dissolved drug respectively excipient particle to diffuse across
one subcell.
All other rates are then computed in units of ∆t. Thus, for example, if the average time it takes
for a particle to dissolve is 2 minutes, and ∆t = 0.6 s, which is the time it takes for a dissolved
drug molecule to diffuse across one grid element, then the dissolution step takes, on average, 1200.6 =
200 diffusion steps. We incorporate this variable dissolution rate by decreasing the probability of
dissolution by a factor of 200, so that, on average, it will take 200 iterations of the algorithm for
the particle to start to dissolve. See Table A for the default values of o and l, the average increase
in time to dissolution of drug and excipient particles, respectively.
D. Release profiles and CA output
After all cell states have been updated, the simulation clock is advanced it by ∆t, and we calculate
the percent drug remaining in the tablet. We assume that all of the drug in a D cell can be dissolved
in a water cell. We will return to this assumption in Section IV.
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Let nD(t) be the number of grid cells in state D at time t, so that nD(0) is the number of grid
cells initially in state D. Similarly, let W(t) denote the set of all wet cells in the tablet at time t.
fraction of the initial drug load in the tablet at time t is
M(t) =
nD(t) +
∑
x∈W(t) c(x, t)
nD(0)
.
The fraction released at time t is the complement of the fraction of drug in the tablet at that time:
R(t) = 1−M(t) = 1− nD(t) +
∑
x∈W(t) c(x, t)
nD(0)
.
The simulation is stopped once a user-specified time has been reached, or when drug is no longer
released, i.e. when R′(t) is (approximately) zero. The algorithm detects that drug release has
stopped when the fraction released has not changed by more than 10−5 in 100 consecutive steps.
III. RESULTS
The algorithm above has been implemented using C++ in the package celldiff and is available
at [15]. The simulation time and the fraction of drug released up to that time are exported in ascii
format and can easily be read using open source languages such as gnuplot or scilab. In addition,
the program gives the user the option to export the status of all cells at selected time points as
an ascii file, allowing for better insight into the wetting and dissolution processes, see Figure 6.
The state of the simulated tablet suggests explanations for further experimental observations. For
example, Lemaire et al. [4] asked what is the cause of the differences between the initial release
of drug and the later release. The CA model describes three phases, namely the uptake of water
into the tablet, the dissolution of solid drug and excipient, which causes the formation of pores and
finally the diffusion of dissolved drug out of the tablet. Figure 6 shows an interior slice of a tablet
8mm in diameter during the initial 8 minutes of simulation. The water enters the tablet rapidly,
dissolving the soluble particles of drug and excipient. The interface between solid and dissolved
drug is approximately circular in cross-section, and with our choice of parameters, the radius of
the dry region is decreasing at approximately 160µmmin−1. Such predictions can be tested by
immersing dry tablets in a dyed solution for different periods of time.
In Figure 7 we show the simulated release profile of a drug from a matrix tablet of n = 0.8 cm
diameter with parameters as in Table I. There is strong qualitative agreement with experimental
release profiles published in the literature, see e.g. [7, Figure 7], [13, Figures 1-4], [14, Figure 2] and
[16, Figures 1-3]. The agreement here is understood as the presence of the following features.
• Higher polymer fractions in the powder mixture result in partial release, with the released
fraction decreasing as the polymer fraction increases.
• The early phase of the release is convex, while the later phase is concave.
• The release occurs over approximately 8h.
We can study the influence of the individual parameters on the shape of the release profiles by
varying them one at a time, see Figure 8. An increase of the parameter b (Figure 8, top left panel),
the increased clustering of polymer particles in the outer shell, results in a delayed drug release. In
the case of higher polymer fractions, this can amount to an almost complete trapping of the drug.
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Without compression With compression
0 1 2 3 4 5 6 7 80
0.2
0.4
0.6
0.8
1
t(h)
R(t)
 
 
without compression
with compression
FIG. 5: Simulated tablets before and after compression. Left and middle: a slice of the tablet
before and after compression. Polymer cells are lighter, drug and excipient are gray, and boundary,
wet or void cells are black. The lightest cells (middle panel) are cells in which polymer and drug
are mixed. Right: Release curves for a tablet with compression and without compression. Each
tablet contains 50% polymer. Other parameters are as given in Table I.
The stirring of the surrounding fluid [8] decreases the concentration of dissolved drug outside the
tablet and thereby facilitates the diffusion, although this effect is of somewhat limited size. Clearly,
this is of importance mostly for experiments in rotating disk apparatuses and similar devices. An
increase of either the diffusion rate k or the dissolution rate, o results in a faster release of the drug.
We remark here that the dissolution parameters o and l affect the rate of erosion of the tablet, and
hence their effect is most noticeable at the initiation of release. The parameter k affects the rate
at which drug diffuses from the tablet, and so has a more pronounced effect over the entire release
curve.
IV. DISCUSSION
From our simulations we gain insight on the role that the individual parameters play and how
they influence the drug release profiles. Of course, it has to be borne in mind that some parameters
cannot be manipulated in the process of tablet formulation and fabrication, such as dissolution and
diffusion rates. Roughly speaking, we can group the parameters into two categories, namely those
that determine the size of the tablet and those that determine its topology. In the former category
are the diffusion rate u, the dissolution rate o and, naturally, the tablet diameter n. In the latter
category are the width of the melted polymer shell w and the imbalance factor b that models how
much more the polymer particles are clustered in the melting zone at the edge of the tablet.
A natural question is the powder composition necessary to produce an “ideal” tablet, with a
largely linear release profile and a almost complete release of the (expensive) drug. According
to our simulation results and consistent with experimental evidence [13], thermal treatment after
compression causes drug to be trapped, except at very low polymer fractions. At these low polymer
fractions, however, drug is released very quickly since most of the tablet erodes. Therefore, in order
to get complete release of the drug over 8 hours, with a nearly linear release profile, the model
suggests using a polymer fraction between 40 and 45%, with as little deformation and fusing of
the polymer particles as possible. We illustrate this in Figure 9, which shows simulations in which
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FIG. 7: Simulation of drug release from a tablet of n = 0.8 cm diameter using the parameters in
Table I.
the compression sub-routine is disabled (flag d is set to 0). Note that in this model we assume
brittle drug and excipient, such as indomethacin and lactose, and a deformable, non-soluble, non-
permeable polymer. If the properties of the particles are changed, then the model must be modified
accordingly. For a release profile close to the ideal it is desirable to put a shell of polymer on the
tablet without completely enclosing the interior. In our model, we set b = 2, but we do not apply
compression or heating. With 30% polymer, we get a close to ideal release over 8 hours, and higher
polymer concentrations extend the release profile over longer time intervals. See Figure 9 (right
panel).
Of the possible drug release mechanisms, our model mimics the transport of drug molecules
through water filled pores. As time passes, degradation of the excipient and drug particles occurs
and many crevices and channels are formed. The diffusion through these pores is highly dependent
on the polymer structure and consequently also dependent on the processes that alter pore formation
and closure [1]. As it can be seen in Figure 5, the spreading and fusing of polymer particles after
compression and thermal treatment changes the tablet structure and modifies the tortuosity, pore
formation and the resulting release curves. This structural change is crucial to reproduce the
trapping of drug at high polymer concentrations observed in experimental data. Without it, the
release obtained at high polymer concentrations did not match that of the experimental data.
The initial burst release observed in Figure 7 for all polymer densities, can be attributed to drug
particles easily accessible by hydration on the surface [1, 17]. Thus, to match the very low rate
of drug release present at high curing temperatures and high polymer content, we implement the
formation of a polymer shell on the surface of the tablet. As described in [13], the effect of thermal
treating causes a better coalescence of polymer particles with a decreased porosity and a smoother
surface. By altering the morphology of the outer layer, we successfully control the permeability and
eliminate the initial burst, providing a more faithful picture of the experimental results.
To include other release mechanisms such as diffusion through the polymer or degradation of
the polymer in our mathematical model, it will be necessary to describe the diffusion coefficient as
a function of other parameters. The diffusion rate through a polymer is highly dependent on its
physical state. For some polymers, there is a glass temperature transition in which the polymer
changes from brittle to rubber-like. In this case, the diffusion rate can change by several orders
of magnitude [1]. For biodegradable polymers, modeling the dissolution of the polymer and the
corresponding matrix degradation might require a non-constant diffusion coefficient that varies in
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FIG. 8: Simulation of drug release from a tablet of n = 0.8 cm diameter while changing parameters.
The dashed lines correspond to the default parameters in Table I.
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FIG. 9: (Left) Simulated release curves for tablets containing 40, 45 and 50 % polymer, modeling
no compression or thermal treatment. The compression flag, d, is set to 0. All other parameters
are in Table I. (Right) Simulated release curves for tablets containing 30, 40 and 45 % polymer,
with no compression (d = 0), with an imposed shell of polymer, b = 2. Comparison is made to a
tablet with 40% polymer and no shell. The release curves are close to the “ideal”, depending on
the desired release interval.
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proportion to the local fraction of polymer in the tablet [18].
The role of the excipient in our model is merely that of a space filler, which is not to say that it is
not important. Dissolving excipient opens new channels through which water can reach the drug,
and through which the drug can diffuse out of the tablet. It should be stressed that our assumption
that drug and excipient dissolve independently of each other in water is a simplification. A water cell
whose water is saturated with respect to excipient should have a very small capacity to dissolve drug
and vice versa. Furthermore, the current assumption that the entire mass of drug in one grid cell
can be dissolved in the amount of water in a grid cell of the same volume is another simplification.
A more realistic implementation of the model would incorporate a gradual dissolution process, so
that only a fraction of the drug in a D cell is dissolved in one simulation step.
One simulation representing 8 hours with the baseline parameters given in Table I typically
takes one hour on a MacPro workstation (6-Core Intel Xeon at 2.93GHz). The algorithm is easily
parallelizable, which is one of the positive features of a CA model. This is work in progress.
Appendix A: Sample call and parameter values
A sample call of the code is as follows: user-supplied arguments are preceded by a hyphen, and
successive arguments are separated by spaces. For example, the call
./celldiff -n 0.8 -p 0.3 -c30000 -t100 -sTabletData.txt
calls the program simulating a tablet with diameter n = 0.8 cm, made up of 30% polymer and
10% drug (the default). It simulates the evolution of the tablet over 3 · 104 s and exports the full
state data every 100 time steps, storing it in the text file TabletData.txt. Table I lists the model
parameters and their default values in the program, celldiff.
Appendix B: Derivation of the diffusion update rule
Let c(x, t) be the concentration of a substance at a point x ∈ R3 at time t ∈ R. The diffusion
equation in three dimensions is
∂c
∂t
= D∆c
where ∆ denotes the usual Laplace operator in three dimensions and D is the diffusion constant
(with units Length2/Time). After discretization of space on a cubic lattice with lattice constant L
and of time, so that x = (i, j, k) and tm = m∆t, the discretized version of the diffusion equation
becomes
c(x, tm+1)− c(x, tm) = D∆t
L2
 ∑
y∈N(x)
c(y, tm)− 6c(x, tm)
 , (B1)
where N(x) is the von Neumann neighborhood of x. In the CA model, we choose ∆t to be the
expected time it would take for a dissolved particle to diffuse across one grid element, of side length
L. Since the variance of the diffusion process, X(t), is given by E[X2] = 6Dt, we choose the
time step, ∆t so that L2 = 6D∆t and hence ∆t = L
2
6D , where D = max{Ddrug, Dexcipient} is the
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Name User Input Meaning Default Value Units/Range
diameter n diameter of the computa-
tional domain
0.8 cm
maxtime c maximum time to simulate
before halting
30000 s
polymer p polymer concentration 0.3 [0, 1]
drug g drug concentration 0.1 [0, 1]
tablet height h height of tablet as a ratio
of diameter
0.23 [0, 1]
release file r filename for exporting re-
lease curve
time stamped name
state file s filename for exporting full
state data
time stamped name
stateperiod t how often to export full
state data
0 (never)
compress d flag to indicate whether
or not compression and
thermal treatment is
implemented
1 1 or 0
seed e random number seed 47 N
asciiperiod a frame period in iterations
for drawing ascii animation
1 N
drugdissprob o dissolution probability
scale for drug
10−3
exdissprob l dissolution probability
scale for excipient
10−3
polyshellbalance b distribution of polymer in
the shell
1 ≥ 1
removal rate f removal factor for concen-
trations in boundary cells
0.95 [0, 1]
nographics x set > 0 to run in non-
interactive, text-only mode
1
drugdiffrate u physical rate of drug
diffusion
7 · 10−6 cm
s2
exdiffrate k physical rate of excipient
diffusion
7 · 10−6 cm
s2
cellsize y physical size of a cell 0.01 cm
polyshellwidth w width of the polymer shell
(has no effect when b = 1,
the default)
1 cell size
TABLE I: Default values of the parameters in celldiff.
maximum of the diffusion rates of the drug and excipient. Substituting this value of ∆t into the
discretized diffusion equation, equation (B1), and rearranging gives
c(x, tm+1) = c(x, tm) + Dˆ
 ∑
y∈N(x)
c(y, tm)− 6c(x, tm)
 (B2)
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where Dˆ =
Di
6 max{Ddrug, Dexcipient} , where i is “drug” or “excipient”, depending on the concen-
tration that is updated. In this model, certain neighbors might contain solid particles of drug or
excipient, or polymer. We impose zero flux conditions on the boundaries to these solid neighbors,
so that only terms involving neighboring cells in the “wet” (W) state are counted in the expression
in equation (B2). This gives the diffusion update rule described above.
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